Roche Holding AG (OTCQX International Premier:RHHVF)

239.33
Delayed Data
As of Feb 22
 +1.33 / +0.56%
Today’s Change
227.00
Today|||52-Week Range
276.80
-4.65%
Year-to-Date
Will Mylan (MYL) Disappoint Investors This Earnings Season?
Feb 22 / Zacks.com - Paid Partner Content
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock
Feb 15 / Zacks.com - Paid Partner Content
Will Cabometyx Fuel Exelixis' (EXEL) Earnings in Q4 Again?
Feb 21 / Zacks.com - Paid Partner Content
Prothena's (PRTA) Loss Narrows in Q4, Pipeline Progresses
Feb 15 / Zacks.com - Paid Partner Content
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock (Revised)
Feb 16 / Zacks.com - Paid Partner Content
Roche's Rituxan Gets Priority Review for Label Expansion
Feb 14 / Zacks.com - Paid Partner Content
Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion
Feb 16 / Zacks.com - Paid Partner Content
Exelixis Reports Positive Data From Thyroid Carcinoma Trial
Feb 14 / Zacks.com - Paid Partner Content
AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan
Feb 16 / Zacks.com - Paid Partner Content
Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth?
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close238.00
Today’s open238.45
Day’s range238.45 - 239.33
Volume7
Average volume (3 months)4,815
Market cap$168.1B
Data as of 2:45pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-9.88%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.48%
P/E ratio17.3
Price/Sales4.02
Price/Book7.53

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$54.2B
Annual profit (last year)$8.8B
Net profit margin16.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts